Cargando…

Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer

The purpose of this study was to explore the relationship between bladder urothelial cancer (BLCA) and immunity, to screen prognosis-related immune genes (PIGs), and to construct an immune-related prognosis model (IRPM). We processed the relevant data of The Cancer Genome Atlas (TCGA-BLCA) and GSE13...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiange, Huang, Caisheng, Yang, Rirong, Wang, Xiang, Fang, Bo, Mi, Junhao, Yuan, Hao, Mo, Zengnan, Sun, Yihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687876/ https://www.ncbi.nlm.nih.gov/pubmed/36421685 http://dx.doi.org/10.3390/biom12111670

Ejemplares similares

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism‐related genes and their relationships with immune infiltration
por: Huang, Caihong, et al.
Publicado: (2023)

Identification and validation of molecular subtypes’ characteristics in bladder urothelial carcinoma based on autophagy-dependent ferroptosis
por: Liu, Shiwei, et al.
Publicado: (2023)

Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model
por: Nie, Shiwen, et al.
Publicado: (2022)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
por: Cheng, Lang, et al.
Publicado: (2023)

Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma
por: Hu, Jianpei, et al.
Publicado: (2023)

Analysis of prognostic oncogene filaggrin (FLG) wild-type subtype and its implications for immune checkpoint blockade therapy in bladder urothelial carcinoma
por: Chen, Liang, et al.
Publicado: (2022)

Independent prognostic miRNAs for bladder urothelial carcinoma
por: Hu, Yingbo, et al.
Publicado: (2017)

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)
por: Xing, Qianwei, et al.
Publicado: (2020)

Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer
por: Li, Xiaoxiao, et al.
Publicado: (2022)

Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma
por: Luo, Qizhan, et al.
Publicado: (2020)

KDELR2 as a diagnostic and prognostic biomarker of bladder urothelial carcinoma and its correlation with immune infiltration
por: Ma, Sai, et al.
Publicado: (2023)

Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis
por: Li, Yuxin, et al.
Publicado: (2021)

Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
por: van Wilpe, Sandra, et al.
Publicado: (2020)

A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma
por: Wang, Chengbang, et al.
Publicado: (2022)

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder
por: Kucuk, Ulku, et al.
Publicado: (2015)

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2021)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder
por: Luo, Yuzhen, et al.
Publicado: (2018)

Corrigendum to “Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma”
por: Luo, Qizhan, et al.
Publicado: (2021)

Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis
por: Na, Lei, et al.
Publicado: (2020)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes
por: Wang, Guangyao, et al.
Publicado: (2023)

Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma
por: Guo, Ya, et al.
Publicado: (2022)

PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
por: Ni, Wenpeng, et al.
Publicado: (2023)

Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma
por: Xiang, An-Ping, et al.
Publicado: (2022)

Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma
por: Gao, Yukui, et al.
Publicado: (2022)

Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis
por: Xing, Peng, et al.
Publicado: (2022)

Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer
por: Zhou, Liquan, et al.
Publicado: (2023)

Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Li, Hanwen, et al.
Publicado: (2021)

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma
por: Mo, Miao, et al.
Publicado: (2021)

Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer
por: Stojnev, Slavica, et al.
Publicado: (2019)

Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
por: Meireles, Sara, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_thm4nlei9io93k3trpdqbonmi1